Estrigenix Therapeutics

Prescription Drugs · Health Care

Overview

ABOUT What We Do Estrigenix Therapeutics, Inc. was formed in 2018 to develop and commercialize first-in-class therapeutics to treat and prevent hot flashes and dementia in post-menopausal women.

Funding and backers

Total raised
$1M
2 rounds on record
Latest round
$1M
Venture round · Jul 2026 · 3 mo ago
Team
1-10
employees, estimated range
Grants
$299k
1 grant · CORDIS
The money's age
Fresh money
3 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 17 Raised a round Venture round $1M · SEC Form D Sep 15, 2022 Won a grant $299k · CORDIS
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jul 2026 $1M — SEC Form D
Grant Sep 2022 $299k — CORDIS
Registers and programsofficial lists and records that name the company
Legal entity ESTRIGENIX THERAPEUTICS, INC. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Daniel SemExecutive Officer, DirectorSEC Form D
William DonaldsonExecutive Officer, DirectorSEC Form D
Karyn FrickExecutive OfficerSEC Form D
Victoria ZellmerExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Techstars
backs Validproof
F-Prime Capital
backs Engrail Therapeutics
E14 Fund
backs Amira Health
Foresite Capital
backs Engrail Therapeutics
Eight Roads
backs Engrail Therapeutics
M Ventures
backs iOnctura
Similar startupsby what they do, their industry and backers
iOncturaSeries B $86.4M · 2 yr ago · Founded 2016 · 201-500 employees
Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at…
JuvlabsConvertible Note $9.5M · 5 yr ago · Founded 2017 · 51-200 employees
We extend healthy lifespan through developing innovative medicines that target core aging mechanisms to not only treat but prevent…
Oisinbio
Oisín Biotechnologies develops genetic medicines to address age-related diseases.
Azurity PharmaceuticalsVenture round $1.1B · 7 mo ago · 6 roles
Azurity Pharmaceuticals is a privately held specialty pharmaceutical company that develops and markets medicines for patients underserved…
Amira HealthVenture round $2.8M · 4 yr ago · Founded 2020 · 11-50 employees
Terra is the first automatic cooling pad that keeps you sleeping through your night-time hot flashes. The Bracelet detects a hot flash, the…
TILT BiotherapeuticsSeries B $25M · 17 mo ago
About TILT TILT Biotherapeutics is the world's leading company developing oncolytic immunotherapies to enable T-cell therapies for solid…

Financials

Total raised
$1.3M
Latest round
Venture - Series Unknown
Funding rounds
2
Funding rounds
Round Announced Amount
Venture - Series Unknown 2026 $1M Details
Grant 2022 $299k Details

People

Daniel Sem
Executive Officer, Director
SEC Form D
William Donaldson
Executive Officer, Director
SEC Form D
Karyn Frick
Executive Officer
SEC Form D
Victoria Zellmer
Executive Officer
SEC Form D
Patricia Scheller
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Wauwatosa United States
HQ
1-10 est. staff